Head-to-head · WeighScore
DreamHug Medical vs FMmeds
The verdict
FMmeds takes it — 63.2/100 to 57.9/100.
FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | DreamHug Medical | FMmeds |
|---|---|---|
| WeighScore | 57.9/100 | 63.2/100 |
| Grade | C | C |
| Scorecard rank | #386 | #257 |
| Semaglutide | $188/mo (starting dose, compounded) | $225/mo (all doses, compounded) |
| Tirzepatide | $238/mo (starting dose, compounded) | $265/mo (all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #386 · C
Strengths
- Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
- 100% money-back guarantee if you're not approved
- Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
- LegitScript logo displayed
Where it loses points
- Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
- Pricing not disclosed — fully gated behind sign-up
- LegitScript ID number not shown (only the logo)
- Pharmacy partner not disclosed
- Named medical director not disclosed
Graded #257 · C
Strengths
- All 50 states plus DC covered, stated in the Terms
- Operating LLC and full Manhattan Beach, CA address disclosed
- Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
- Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
- Flat pricing across all dose strengths — no dose-escalation surcharge
Where it loses points
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
- Clinical network not separately named
- LegitScript Certified, but the specific ID isn't shown
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.